Gateway Biotechnology Presents at ARO 2025

Written By Boran Li

CEO Bao and CSO Pinkl presented their latest research at ARO 48th Annual MidWinter Meeting this week - Identification of Functional Biomarkers Associated with Age-Related Cochlear Synaptopathy.

Boran Li
Previous

Gateway Biotechnology Publishes an Article in the Journal of the Association for Research in Otolaryngology
Next

Hearing Loss in the Unoperated Ear After High-Speed Drilling in Otologic and Skull Base Surgery